SAB Biotherapeutics, Inc. (SABS)

NASDAQ: SABS · IEX Real-Time Price · USD
4.600
+0.380 (9.00%)
Mar 28, 2024, 3:25 PM EDT - Market closed

Total Valuation

SABS has a market cap or net worth of $41.88 million. The enterprise value is $44.11 million.

Market Cap 41.88M
Enterprise Value 44.11M

Important Dates

The next estimated earnings date is Tuesday, May 14, 2024, before market open.

Earnings Date May 14, 2024
Ex-Dividend Date n/a

Share Statistics

SABS has 9.23 million shares outstanding. The number of shares has increased by 21.79% in one year.

Shares Outstanding 9.23M
Shares Change (YoY) +21.79%
Shares Change (QoQ) +3.94%
Owned by Insiders (%) 19.03%
Owned by Institutions (%) 38.88%
Float 3.36M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.23
Forward PS n/a
PB Ratio 2.75
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10.77
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.30.

Current Ratio 0.34
Quick Ratio n/a
Debt / Equity 0.30
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -82.62

Financial Efficiency

Return on equity (ROE) is -120.40% and return on invested capital (ROIC) is -135.93%.

Return on Equity (ROE) -120.40%
Return on Assets (ROA) -69.20%
Return on Capital (ROIC) -135.93%
Revenue Per Employee $73,122
Profits Per Employee -$485,922
Employee Count 56
Asset Turnover 0.10
Inventory Turnover n/a

Taxes

In the past 12 months, SABS has paid $25,629 in taxes.

Income Tax 25,629
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +2.20% in the last 52 weeks. The beta is 0.79, so SABS's price volatility has been lower than the market average.

Beta (1Y) 0.79
52-Week Price Change +2.20%
50-Day Moving Average 5.35
200-Day Moving Average 7.18
Relative Strength Index (RSI) 41.63
Average Volume (30 Days) 18,361

Short Selling Information

The latest short interest is 20,886, so 0.23% of the outstanding shares have been sold short.

Short Interest 20,886
Short Previous Month 24,545
Short % of Shares Out 0.23%
Short % of Float 0.62%
Short Ratio (days to cover) 0.83

Income Statement

In the last 12 months, SABS had revenue of $4.09 million and -$27.21 million in losses. Loss per share was -$5.70.

Revenue 4.09M
Gross Profit 4.09M
Operating Income -27.06M
Pretax Income -27.19M
Net Income -27.21M
EBITDA -23.14M
EBIT -26.86M
Loss Per Share -$5.70
Full Income Statement

Balance Sheet

The company has $2.43 million in cash and $4.65 million in debt, giving a net cash position of -$2.23 million or -$0.24 per share.

Cash & Cash Equivalents 2.43M
Total Debt 4.65M
Net Cash -2.23M
Net Cash Per Share -$0.24
Equity / Book Value 15.26M
Book Value Per Share 1.65
Working Capital -6.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.46 million and capital expenditures -$202,594, giving a free cash flow of -$11.66 million.

Operating Cash Flow -11.46M
Capital Expenditures -202,594
Free Cash Flow -11.66M
FCF Per Share -$2.23
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -660.87% and -664.53%.

Gross Margin 100.00%
Operating Margin -660.87%
Pretax Margin -663.91%
Profit Margin -664.53%
EBITDA Margin -565.01%
EBIT Margin -655.97%
FCF Margin -284.71%

Dividends & Yields

SABS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.79%
Shareholder Yield -21.79%
Earnings Yield -64.97%
FCF Yield -27.84%

Analyst Forecast

The average price target for SABS is $20.00, which is 334.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.00
Price Target Difference 334.78%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 5, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date Jan 5, 2024
Split Type Reverse
Split Ratio 1:10

Scores

SABS has an Altman Z-Score of -4.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.64
Piotroski F-Score 2